We have had success with the following profiles in the past. Please click each profile to view the success stories.
Arrayit corporation is the new company profile for January 30th 2012. Redhotstocks.com and all officers owned 64,000 shares. The company’s vagueness from this recent Headline Press Release Led Redhotstocks.com and Officers to believe this was exactly what the headline Read . Copied and pasted from yahoo news : Arrayit Corporation Announces Stock Dividend Distribution Date for Shareholders. This caused the officers of Redhotstocks.com to sell 64,000 shares of ARYC at an average price between .19 and .28 believing the headline was announcing the date to own the stock to receive the Diagnostics Division of the company. This however is not the case. If you read further into the press release the company on 5/2/2012 stated on the phone that the Record date had not yet been announced . Redhotstocks.com can only say that the vagueness of the press release and now more clarity would cause Redhotstocks.com to NOT BE ABLE TO GIVE ANY ADVICE TO THE PUBLIC WHETHER TO BUY OR SELL ARYC AFTER A PHONE CALL TO THE COMPANY CLARIFYING THAT THE RECORD DATE HAS YET TO BE ANNOUNCED. Taken from Arrayits most recent press release regarding upcoming spin-off. Arrayit Corporation (OTCQB: ARYC) announces today that the shareholder stock dividend in the new spin-off Arrayit Diagnostics, Inc. (AD) will be determined by the number of ARYC shares owned as of the record date, which is expected to occur by the end of the first quarter, March 30th, 2012. Upon completion of the spin-off, AD will operate as an independent entity and its common stock will trade as a new ticker symbol on either the NASDAQ or OTCQB. AD CEO John Howell will lead the new company, and is expanding its executive team and forming a Scientific Advisory Board.
Press Release: Arrayit Corporation – Wed, Feb 15, 2012 8:00 AM EST
The following information is a breakdown of the company and a few highlights of why Redhotstocks.com believes the company’s early detection cancer tests will save a lot of lives and thus making the company significantly more valuable than todays current share price.
Redhotstocks.com and all operating officers have no affiliation with any companies mentioned and have not been paid any cash or stock. Redhotstocks.com remains dedicated to bringing the most provectus companies to the forefront of the investment community that are doing their part to save humanity and create a better world for tomorrow.
Business Description
Arrayit leads professionals in the microarray industry by developing, manufacturing and marketing life science tools and integrated laboratory platforms for the analysis of genetic variation, biological function, and diagnostics. Arrayit provides it specialized equipment, tools, microarray manufacturing services to more than 10,000 research laboratories, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies around the globe.
Arrayit competes with large and small, public and private companies. The industry has been historically dominated by Affymetrix which achieved strong market penetration by being the first public company to commercialize and promote microarray applications. A more recent entry to the market, Illumina, has taken significant market share from Affymetrix. However, both competitors face mid to long term scientific and technological challenges because they are limited by what they can deposit onto a microarray–DNA. Arrayit’s patented printing technology can deposit any kind of molecule into a microarray, including DNA, proteins, antibodies, diagnostic elements and other compounds. These next generation microarrays represent the largest growth opportunity in the industry. Arrayit has a long-term advantage in its unique line of personal and high throughput microarray printers, highest sensitivity microarray scanners, top quality consumables, patented diagnostic methods, collaborative corporate culture, and competitive pricing.
ARYC Security Details
Share Structure
Market Value1 $7,814,484 a/o Jan 30, 2012
Shares Outstanding 26,946,496 a/o Sep 30, 2011
Float 11,607,500 a/o Aug 12, 2011
Authorized Shares 480,000,000 a/o Jun 30, 2011
Par Value 0.001
Shareholders
Shareholders of Record 377 a/o Mar 31, 2010
Contact Info
524 East Weddell Drive
Sunnyvale, CA 94089
Website: http://www.arrayit.com
Phone: 408-744-1711
Email: arrayit@arrayit.com
The Sunnyvale, Calif.-based array products and services provider intends to distribute to its existing shareholders its 78.18 percent interest in Arrayit Diagnostics as a stock dividend. The distribution date and further details are expected to be announced early in the first quarter of 2012. Upon gaining independence, Arrayit Diagnostics expects to be listed on the Over-the-Counter Bulletin Board securities market in the US.
Paul Haje, Arrayit’s vice president of sales and marketing, told BioArray News this week that the company is spinning off Arrayit Diagnostics in order to attract investments that will facilitate the regulatory clearance and commercialization of its tests, the farthest along of which is OvaDx, an array-based diagnostic for early-stage ovarian cancer.
“We have investors who really want to make a focused investment in Arrayit Diagnostics, and who want to be involved in the milestones associated with that,” Haje said.
Haje said that Arrayit Diagnostics is in negotiations with a potential investor — a company that is a “household word” and “wants to get into microarrays and life sciences” — but he declined to name the interested party.
PRRY is being retired into Redhotstocks’s profile success stories. 375,000 shares were purchased in the open market at or below .02 . All shares were liquidated during the week of January 23rd, 2012. Redhotstocks.com continues to believe in the company and sold for profit taking and being able to act on better investment opportunities in the market at this time. The shares were sold between .04-.06 for a 300% gain. Anytime you experience over a 100% return it’s always a good idea to lock in all or most of your profits depending on your risk level. Another good indicator of when to lock profits in is the long and short term RSI .
2009 ASFX Stock Profile Success
Asfx was originally bought and Profiled at a dollar cost average of .003 over several months beginning in July of 2009.
A small portion of Asfx was sold at .0125 in 2010 and bought back at .0081 , .0085 , and .088.
Approximately 3.4 million shares were liquidated At an average of .015 on March 29, 2010 Due to other investment opportunities in the market.
ASFX has been retired from being profiled on Redhotstocks.com based on the recent discovery of the s-1 filing which was filed on January 26, 2010